Coxarthrosis. Clinic, diagnosis and treatment: clinical guidelines (abridged version)

Cover Page

Cite item

Full Text

Abstract

Coxarthrosis is a heterogeneous group of diseases with various etiologies and similar biological, morphological, clinical manifestations and outcomes, which are based on damage to all components of the joint: cartilage, subchondral bone, synovium, ligaments, capsule, and periarticular muscles. Clinical guidelines are the main working tool of a practicing physician, both a specialist and a narrow practice doctor. Conciseness, structuredness of information about a particular nosology, methods of its diagnosis and treatment, based on the principles of evidence-based medicine, allow to give in a short time one or another answer to a question of interest to a specialist, to achieve maximum efficiency and personalization of treatment. These clinical guidelines include data on the classification, clinical presentation, diagnosis, and treatment of coxarthrosis. In addition, they provide methods for the rehabilitation of patients with this pathology.

About the authors

Rashid M. Tikhilov

Russian Scientific Research Institute of Traumatology and Orthopedics named after R.R. Vreden

Email: rtikhilov@gmail.com
ORCID iD: 0000-0003-0733-2414
SPIN-code: 3602-4912

MD, Dr. Sci. (Med.), professor

Russian Federation, Saint Petersburg

Aleksandr M. Lila

V.A. Nasonova Research Institute of Rheumatology

Email: profput@mail.ru
ORCID iD: 0000-0002-6068-3080
SPIN-code: 7287-8555

MD, Dr. Sci. (Med.), professor

Russian Federation, Moscow

Aleksandr Yu. Kochish

Russian Scientific Research Institute of Traumatology and Orthopedics named after R.R. Vreden

Email: auk1959@mail.ru
ORCID iD: 0000-0002-2466-7120
SPIN-code: 7522-8250

MD, Dr. Sci. (Med.), professor

Russian Federation, Saint Petersburg

Lyudmila I. Alekseeva

V.A. Nasonova Research Institute of Rheumatology

Email: dr.alekseeva@gmail.com
ORCID iD: 0000-0001-7017-0898
SPIN-code: 4714-8572

MD, Dr. Sci. (Med.), professor

Russian Federation, Moscow

Igor I. Shubnyakov

Russian Scientific Research Institute of Traumatology and Orthopedics named after R.R. Vreden

Email: shubnyakov@mail.ru
ORCID iD: 0000-0003-0218-3106
SPIN-code: 3531-7679

MD, Dr. Sci. (Med.)

Russian Federation, Saint Petersburg

Alexey O. Denisov

Russian Scientific Research Institute of Traumatology and Orthopedics named after R.R. Vreden

Email: med-03@ya.ru
ORCID iD: 0000-0003-0828-7678
SPIN-code: 2084-8670

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Svetlana A. Bozhkova

Russian Scientific Research Institute of Traumatology and Orthopedics named after R.R. Vreden

Email: clinpharm-rniito@yandex.ru
ORCID iD: 0000-0002-2083-2424
SPIN-code: 3086-3694

MD, Dr. Sci. (Med.)

Russian Federation, Saint Petersburg

Dmitry V. Stafeev

Russian Scientific Research Institute of Traumatology and Orthopedics named after R.R. Vreden

Email: dvstafeev@rniito.ru
SPIN-code: 9042-2348

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Tatyana V. Builova

Lobachevsky State University of Nizhni Novgorod

Email: tvbuilova@list.ru
ORCID iD: 0000-0003-0282-7207
SPIN-code: 6062-2584

MD, Dr. Sci. (Med.), professor

Russian Federation, Nizhny Novgorod

Reseda A. Bodrova

Kazan State Medical Academy — Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education”

Email: bodrovarezeda@yandex.ru
ORCID iD: 0000-0003-3540-0162
SPIN-code: 1201-5698

MD, Dr. Sci. (Med.), docent

Russian Federation, Kazan

Mikhail B. Tsykunov

N.N. Priorov National Medical Research Center of Traumatology and Orthopedics; Pirogov Russian National Research Medical University

Author for correspondence.
Email: rehcito@mail.ru
ORCID iD: 0000-0002-0994-8602
SPIN-code: 8298-8338

MD, Dr. Sci. (Med.), professor

Russian Federation, Moscow; Moscow

Yulia A. Israelyan

Privolzhsky Research Medical University

Email: ija07@yandex.ru
ORCID iD: 0000-0002-4480-1884
SPIN-code: 6334-6564

MD, Cand. Sci. (Med.), docent

Russian Federation, Nizhny Novgorod

References

  1. NCCCC – National Collaborating Centre for Chronic Conditions. Osteoarthritis: national clinical guideline for care and management in adults. London: Royal College of Physicians; 2008.
  2. Hunter D. Focusing osteoarthritis management on modifiable risk factors and future therapeutic prospects. Ther Adv Musculoskelet Dis. 2009;1(1):35–47. doi: 10.1177/1759720X09342132
  3. Lane NE, Brandt K, Hawker G, et al. OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthritis Cartilage. 2011;19(5):478–482. doi: 10.1016/j.joca.2010.09.013
  4. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697–1707. doi: 10.1002/art.34453
  5. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23(5):471–478. doi: 10.1097/BOR.0b013e328349c2b1
  6. Oben J, Enonchong E, Kothari S, et al. Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study. Nutr J. 2009;8:38. doi: 10.1186/1475-2891-8-38
  7. Stasevich NYu, Sarkisov KA, Smyslov IN, Uchaikin JN. Osteoarthritis of the hip joint as a medical social health problem. Klinicheskii opyt Dvadtsatki. 2015;(2):48–51. (In Russ).
  8. Kc R, Li X, Forsyth CB, et al. Osteoarthritis-like pathologic changes in the knee joint induced by environmental disruption of circadian rhythms is potentiated by a high-fat diet. Sci Rep. 2015;5:16896. doi: 10.1038/srep16896
  9. Jonsson H, Eliasson GJ, Jonsson A, et al. High hand mobility is associated with radiological CMC1 osteoarthritis: the AGES-Reykjavik study. Osteoarthritis Cartilage. 2009;17(5):592–595. doi: 10.1016/j.joca.2008.10.002
  10. Harris EC, Coggon D. HIP osteoarthritis and work. Best Pract Res Clin Rheumatol. 2015;29(3):462–482. doi: 10.1016/j.berh.2015.04.015
  11. Al Saleh J, Sayed ME, Monsef N, Darwish E. The prevalence and the determinants of musculoskeletal diseases in Emiratis attending primary health care clinics in Dubai. Oman Med J. 2016;31(2):117–123. doi: 10.5001/omj.2016.23
  12. Nishii T, Tanaka H, Sugano N, et al. Disorders of acetabular labrum and articular cartilage in hip dysplasia: evaluation using isotropic high-resolutional CT arthrography with sequential radial reformation. Osteoarthritis Cartilage. 2007;15(3):251–257. doi: 10.1016/j.joca.2006.08.002
  13. Nishii T, Shiomi T, Tanaka H, et al. Loaded cartilage T2 mapping in patients with hip dysplasia. Radiology. 2010;256(3):955–965. doi: 10.1148/radiol.10091928
  14. Fujii M, Nakashima Y, Jingushi S, et al. Intraarticular findings in symptomatic developmental dysplasia of the hip. J Pediatr Orthop. 2009;29(1):9–13. doi: 10.1097/BPO.0b013e318190a0be
  15. Tikhilov RM, Shubnyakov II, Pliev DG, et al. Rukovodstvo po khirurgii tazobedrennogo sustava. St. Petersburg: RNIITO im. R.R. Vredena; 2014. P. 368. (In Russ).
  16. Akhtyamov IF, Sokolovskii OA. Khirurgicheskoe lechenie displazii tazobedrennogo sustava. Kazan; 2008. 371 р. (In Russ).
  17. Abal’masova EA, Luzina EV. Razvitie tazobedrennogo sustava posle lecheniya vrozhdennogo vyvikha i podvyvikha bedra u detei. Tashkent: Meditsina; 1983. 188 p. (In Russ).
  18. Kamosko MM. Kontseptsiya «organosberezheniya» v rekonstruktivnoi khirurgii displasticheskogo tazobedrennogo sustava. Vestnik Petrovskoi akademii. 2005;(4/1):32–34. (In Russ).
  19. Jacobsen S, Sonne-Holm S. Hip dysplasia: a significant risk factor for the development of hip osteoarthritis. A cross-sectional survey. Rheumatology (Oxford). 2005;44(2):211–218. doi: 10.1093/rheumtology/keh436
  20. Albinana J, Dolan LA, Spratt KF, et al. Acetabular dysplasia after treatment for developmental dysplasia of the hip. Implications for secondary procedures. J Bone Joint Surg Br. 2004;86(6):876–886. doi: 10.1302/0301-620x.86b6.14441
  21. Yoshimura N, Campbell L, Hashimoto T, et al. Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br J Rheumatol. 1998;37(11):1193–1197. doi: 10.1093/rheumatology/37.11.1193
  22. Johnsen K, Goll R, Reikeras O. Acetabular dysplasia as an aetiological factor in development of hip osteoarthritis. Int Orthop. 2009;33(3):653–657. doi: 10.1007/s00264-008-0554-7
  23. Norkin IA, Petrov AB, Zhadenov II, et al. Biological model of displastic coxarthrosis (experimental research). Travmatologiya i ortopediya Rossii. 2006;(4):59–63. (In Russ).
  24. Shevaliev GA. Obosnovanie aktivnoi khirurgicheskoi taktiki pri perelomakh vertluzhnoi vpadiny [dissertation abstract]. St. Petersburg; 1993. S. 19. (In Russ).
  25. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55(8):1629–1632.
  26. Ruesch PD, Holdener H, Ciaramitaro M, Mast JW. Prospective study of surgically treated acetabular fractures. Clin Orthop Relat Res. 1994;(305):38–46.
  27. Gudz AI, Lasunskii SA, Denisov AO, et al. Optimal method of primary total hip arthroplasty after severe acetabular fractures. Sovremennye problemy nauki i obrazovaniya. 2017;(5):147. (In Russ).
  28. Hunter DJ. Focusing osteoarthritis management on modifiable risk factors and future therapeutic prospects. Ther Adv Musculoskel Dis. 2010;1(1):35–47. doi: 10.1177/1759720X09342132
  29. Lazarev AF. Operativnoe lechenie povrezhdenii taza [dissertation abstract]. Moscow; 1992. P. 39. (In Russ).
  30. Buachidze OSh. Perelomovyvikhi v tazobedrennom sustave. Moscow: Moniki; 1993. P. 197. (In Russ).
  31. Kutepov SM. Lechenie perelomov taza s povrezhdeniem vertluzhnoi vpadiny. Travmatologiya i ortopediya Rossii. 1995;(3):13–17. (In Russ).
  32. Nikolaev NS, Malyuchenko LI, Preobrazhenskaya EV, et al. Use of customized acetabular components for hip joint arthroplasty in posttraumatic coxarthrosis. Orthopaedic Genius. 2019;25(2):207–213. (In Russ). doi: 10.18019/1028-4427-2019-25-2-207-213
  33. Loughlin J. The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev Mol Med. 2005;7(9):1–12.
  34. Jonsson H, Eliasson GJ, Jonsson A, et al. High hand mobility is associated with radiological CMC1 osteoarthritis: the AGES-Reykjavik study. Osteoarthritis Cartilage. 2009;17(5):592–595. doi: 10.1016/j.joca.2008.10.002
  35. Lohmander LS, Gerhardsson de Verdier M, Rollof J, et al. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis. 2009;68(4):490–496. doi: 10.1136/ard.2008.089748
  36. Dawson J, Fitzpatrick R, Fletcher K, Wilson R. Osteoarthritis affecting the hip and knee. In: Stevens A, Raftery J, Mant J, Simpson S, editors. Health care needs assessment. Oxford: Radcliffe Publishing; 2004. P. 549–634.
  37. Nevitt MC, Xu L, Zhang Y, et al. Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study. Arthritis Rheum. 2002;46(7):1773–1779. doi: 10.1002/art.10332
  38. March LM, Bagga H. Epidemiology of osteoarthritis in Australia. Med J Aust. 2004;180(Suppl 5):S6–10. doi: 10.5694/j.1326-5377.2004.tb05906.x
  39. Lawrence RC, Hochberg MC, Kelsey JL, et al. Estimated of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Reumatol. 1989;16(4):427–441.
  40. Patel H, Canadian Task Force on Preventive Health Care. Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns. CMAJ. 2001;164(12):1669–1677.
  41. Deineko AN. Khirurgicheskoe lechenie detei shkol’nogo vozrasta s displaziei tazobedrennogo sustava [dissertation abstract]. St. Petersburg; 2006. 23 p. (In Russ).
  42. Peled E, Eidelman M, Katzman A, Bialik V. Neonatal incidence of hip dysplasia ten years of experience. Clin Orthop Relat Res. 2008;466(4):771–775. doi: 10.1007/s11999-008-0132-8
  43. Loskutov AE, Zub TA, Loskutov OA. O klassifikatsii displasticheskogo koksartroza u vzroslykh. Ortopediya, travmatologiya i protezirovanie. 2010;(2):83–87. (In Russ).
  44. Crowe JF, Mani VJ, Ranawat CS. Total hip replacement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg Am. 1979;61(1):15–23.
  45. Hartofilakidis G, Karachalios T. Total hip arthroplasty for congenital hip. J Bone Joint Surg Am. 2004;86(2):242–250. doi: 10.2106/00004623-200402000-00005
  46. Eftekhar NS. Total hip arthroplasty. 7th ed. St. Louis: Mosby; 1993.
  47. Coleman SS. Congenital dysplasia of the hip in the Navajo infant. Clin Orthop Relat Res. 1968;56:179–193.
  48. Dzupa V, Bartonicek J, Skala-Rosenbaum J, Prikazsky V. Mortality in patients with proximal femoral fractures during the first year after the injury. Acta Chir Orthop Traumatol Cech. 2002;69(1):39–44. (In Czech).
  49. Kornilov NV. Sostoyanie endoprotezirovaniya krupnykh sustavov v Rossiiskoi Federatsii. In: Endoprotezirovanie krupnykh sustavov: Materialy simpoziuma s mezhdunarodnym uchastiem. Moscow; 2000. P. 49–52. (In Russ).
  50. Casaletto JA, Gatt R. Post-operative mortality related to waiting time for hip fracture surgery. Injury. 2004;35(2):114–120. doi: 10.1016/s0020-1383(03)00210-9
  51. Povoroznyuk VV. Zabolevaniya kostno-myshechnoi sistemy i vozrast. Problemy stareniya i dolgoletiya. 2008;17(4):399–412. (In Russ).
  52. Organizatsiya vosstanovitel’nogo lecheniya postradavshikh s povrezhdeniyami opornodvigatel’noi sistemy i ikh posledstviyami. Leningrad; 1985. 29 p. (In Russ).
  53. Voitovich AV, Shubnyakov II, Abolin AB, et al. Lechenie bol’nykh s perelomami proksimal’nogo otdela bedrennoi kosti. Travmatologiya i ortopediya Rossii. 1996;(3):29–32. (In Russ).
  54. Kornilov NV, Voitovich AV, Mashkov VM, Epshtein GG. Khirurgicheskoe lechenie degenerativno-distroficheskikh porazhenii tazobedrennogo sustava. St. Petersburg; 1997. P. 10–13. (In Russ).
  55. Manninen P, Riihimaki H, Feliovaara M, Makela P. Overweight, gender & knee osteoarthritis. Int J Obes Relat Metab Disord. 1996;20(6):595–597.
  56. Listrat V, Ayral X, Patarnello F, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage. 1997;5(3):153–160. doi: 10.1016/s1063-4584(97)80010-6
  57. Kutepov SM, Stel’makh KK, Mineev KP, Shevaliev GA. Eksperimental’no-klinicheskoe obosnovanie lecheniya perelomov vertluzhnoi vpadiny apparatom vneshnei fiksatsii. Travmatologiya i ortopediya Rossii. 1995;(3):18–20. (In Russ).
  58. Milyukov AYu, Pronskikh AA. Modern approaches to treatment of patients with coxal cavity injuries. Politravma. 2006;(1):38–42. (In Russ).
  59. Letournel E. Fractures of the acetabulum. A study of a series of 75 cases. 1961. Clin Orthop Relat Res. 1994;(305):5–9.
  60. Bashurov ZK, Medvedeva NI. Lechenie bol’nykh s perelomami vertluzhnoi vpadiny. Leningrad; 1984. P. 14. (In Russ).
  61. Shapovalov VM. Zakrytye perelomy kostei. Perelomy kostei taza. In: Voennaya travmatologiya i ortopediya. Ed by V.M. Shapovalov. St. Petersburg; 2004. P. 286–297. (In Russ).
  62. Müller ME, Allgöwer M, Schneider R, Willenegger H. Manual of internal fixation. technique recommended by the AO-Group. Transl. from English. Moscow: Ad Marginem; 1996. 750 p. (In Russ).
  63. Alton TB, Gee AO. Classifications in brief: Letournel classification for acetabular fractures. Clin Orthop Relat Res. 2014;472(1):35–38. doi: 10.1007/s11999-013-3375-y
  64. Chiladze IT. Endoprotezirovanie tazobedrennogo sustava pri posledstviyakh perelomov vertluzhnoi vpadiny [dissertation abstract]. St. Petersburg; 2012. P. 43–44. (In Russ).
  65. Brunner A, Ulmar B, Reichel H, Decking R. The Eftekhar and Kerboul classification in assessment of developmental dysplasia of the hip in adult patients. Measurement of inter- and intraobserved reliability. HSS J. 2008;4(1):25–31. doi: 10.1007/s11420-007-9066-z
  66. Springorum HW, Trutnau A, Braun K. Fachlexikon orthopadie: Hufte. Germany: ecomed-Storck GmbH; 1998. 280 p. (In German).
  67. Kosinskaya NS, Rokhlin DG. Rabochaya klassifikatsiya i obshchaya kharakteristika porazhenii kostno-sustavnogo apparata. Leningrad: Meditsina; 1961. 169 p. (In Russ).
  68. Kellgren JH, Jeffrey M, Ball J. Atlas of standard radiographs. Vol 2. Oxford: Blackwell Scientific; 1963.
  69. Pauwels F. Biomechanics of the normal and diseased hip. Berlin; Springer Verlag; 1976.
  70. Bombelli R, Aronson J. Biomechanical classification of osteoarthritis of the hip. In: Schatzker J, editor. The intertrochanteric osteotomy. New York: Springer; 1984. P. 67–134.
  71. Thomas HO. Hip, knee, and ankle. Liverpool: Dobbs; 1976.
  72. Bettelli G. Anaesthesia for the elderly outpatient: preoperative assessment and evaluation, anaesthetic technique and postoperative pain management. Curr Opin Anaesthesiol. 2010;23(6):726–731. doi: 10.1097/ACO.0b013e3283400b6c
  73. Plyushchev AL. Displasticheskii koksartroz. Teoriya i praktika. Moscow: Leto-print; 2007. 495 p. (In Russ).
  74. Rukovodstvo po khirurgii tazobedrennogo sustava. Ed by Tikhilov RM, Shubnyakov II. Vol. 2. St. Petersburg: RNIITO im. R.R. Vredena; 2015. (In Russ).
  75. Kishkovskii AN, Tyutin LA, Esinovskaya GN. Atlas ukladok pri rentgenologicheskikh issledovaniyakh. Leningrad: Meditsina; 1987. 586 p. (In Russ).
  76. Byrd JW. Physical examination. In: Operative Hip Arthroscopy. New York: Springer; 2005. P. 36–50.
  77. Byrd JW, Looney CG. Pelvis, hip, and thigh injuries. In: Madden CC, Putukian M, Young CC, et al. Netter’s sports medicine. Philadelphia, PA: W.B. Saunders; 2010. P. 404–416.
  78. Magee DJ. Orthopedic physical assessment. St. Louis: W.B. Saunders; 2006. 1173 p.
  79. Martin RL, Irrgang JJ, Sekiya JK. The diagnostic accuracy of a clinical examination in determining intra-articular hip pain for potential hip arthroscopy candidates. Arthroscopy. 2008;24(9):1013–1018. doi: 10.1016/j.arthro.2008.04.075
  80. Peck DM. Pelvis, hip, and upper leg. In: McKeag DB, Moeller JL. ACSM’s primary care sports medicine. Philadelphia: W.B. Saunders; 2007. P. 447–459.
  81. Doerti M, Doerti D. Klinicheskaya diagnostika boleznei sustavov. Minsk: Tivali; 1993. 144 p. (In Russ).
  82. Marks VO. Ortopedicheskaya diagnostika. Minsk: Nauka i tekhnika; 1978. 508 p. (In Russ).
  83. International Classification of Functioning, Disability and Health. Short Version. Geneva: World Health Organization; 2001. 173 p.
  84. Shkaly, testy i oprosniki v meditsinskoi reabilitatsii. Moscow; 2002. P. 359–421. (In Russ).
  85. Lequesne M. Indices of severity and disease activity of osteoarthritis. Semin Arthritis Rheum. 1991;20(6 Suppl. 2):48–54. doi: 10.1016/0049-0172(91)90027-w
  86. Rukovodstvo po endoprotezirovaniyu. Ed by Tikhilov RM, Shapovalov VM. St. Petersburg: RNIITO im. R.R. Vredena; 2008. 324 p. (In Russ).
  87. orthopaedicsone.com [Internet]. Hip dysplasia. Orthopaedics One Articles [updated 2012 Jul 25; cited 2021 Aug 12]. Orthopaedics One – The Orthopaedic Knowledge Network [about 2 screens]. Available from: https://www.orthopaedicsone.com/dashboard.action?atl_token=f10a9f9d96c265345958cc20541e9d2c2a86f0fa
  88. Crim J, Oserowsky A, Layfield LJ, Schmidt RL. Comparison of radiography and histopathologic analysis in the evaluation of hip arthritis. AJR Am J Roentgenol. 2019;213(4):895–902. doi: 10.2214/AJR.19.21277
  89. Salem HS, Marchand KB, Ehiorobo JO, et al. Benefits of CT scanning for the management of hip arthritis and arthroplasty. Surg Technol Int. 2020;36:364–370.
  90. Zhao D, Geng H, Feng F, et al. Comparison of SPECT/CT fusion imaging and MRI in benign hip lesions. J Nucl Med. 2010;51(Suppl. 2):1636.
  91. Caruso I, Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. Br Med J. 1980;280(6207):75–78. doi: 10.1136/bmj.280.6207.75
  92. Neumann DA. Biomechanical analysis of selected principles of hip joint protection. Arthritis Care Res. 1989;2(4):146–155. doi: 10.1002/anr.1790020409
  93. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34(5):505–514. doi: 10.1002/art.1780340502
  94. Messier SP, Loeser RF, Miller GD, et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum. 2004;50(5):1501–1510. doi: 10.1002/art.20256
  95. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–350. doi: 10.1016/j.semarthrit.2019.04.008
  96. Minor MA. Exercise in the treatment of osteoarthritis. Rheum Dis Clin North Am. 1999;25(2):397–415. doi: 10.1016/s0889-857x(05)70075-2
  97. Damm P, Schwachmeyer V, Dymke J, et al. In vivo hip joint loads during three methods of walking with forearm crutches. Clin Biomech (Bristol, Avon). 2013;28(5):530–535. doi: 10.1016/j.clinbiomech.2012.12.003
  98. Shrier I, Feldman DE, Gaudet MC, et al. Conservative non-pharmacological treatment options are not frequently used in the management of hip osteoarthritis. J Sci Med Sport. 2006;9(1-2):81–86. doi: 10.1016/j.jsams.2006.02.002
  99. Rannou F, Poiraudeau S. Non-pharmacological approaches for the treatment of osteoarthritis. Best Pract Res Clin Rheumatol. 2010;24(1):93–106. doi: 10.1016/j.berh.2009.08.013
  100. Pascual E. Shoes and lower limb osteoarthritis. J Epidemiol Community Health. 2003;57(10):763–765. doi: 10.1136/jech.57.10.763
  101. Hansen P, English M, Willick SE. Does running cause osteoarthritis in the hip or knee? PM R. 2012;4(5 Suppl):S117–S121. doi: 10.1016/j.pmrj.2012.02.011
  102. Builova TV. Porazheniya myagkikh tkanei i sustavov nizhnei konechnosti. Ed by A.N. Belovа, O.N. Shchepetovа. Vol. 2. Nizhny Novgorod; 1999. P. 384–477. (In Russ).
  103. Fernandes L, Storheim K, Sandvik L, et al. Efficacy of patient education and supervised exercise vs patient education alone in patients with hip osteoarthritis: a single blind randomized clinical trial. Osteoarthritis Cartilage. 2010;18(10):1237–1243. doi: 10.1016/j.joca.2010.05.015
  104. Giraudet-Le Quintrec JS, Coste J, Vastel L, et al. Positive effect of patient education for hip surgery: a randomized trial. Clin Orthop Relat Res. 2003;(414):112–120. doi: 10.1097/01.blo.0000079268.91782.bc
  105. Hurley MV, Walsh NE, Mitchell HL, et al. Clinical effectiveness of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain: a cluster randomized trial. Arthritis Rheum. 2007;57(7):1211–1219. doi: 10.1002/art.22995
  106. Towheed TE, Maxwell L, Anastassiades TP, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2009;2:CD002946. doi: 10.1002/14651 858.cd002 946.pub2
  107. Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;1:CD005614. doi: 10.1002/14651858.CD005614.pub2
  108. Reginster JY. The efficacy of glucosamine sulfate in osteoarthritis:financial and nonfinancial conflict of interest. Arthritis Rheum. 2007;56(7):2105–2110. doi: 10.1002/art.22852
  109. Bartels EM, Bliddal H, Schondorff PK, et al. Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. 2010;18(3):289–296. doi: 10.1016/j.joca.2009.10.006
  110. Honvo G, Reginster JY, Rabenda V, et al. Safety of symptomatic slow-acting drugs for osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging. 2019;36(Suppl. 1):65–99. doi: 10.1007/s4026 6-019-00662-z
  111. Alekseeva LI, Anikin SG, Zaitseva EM, et al. Issledovanie effektivnosti, perenosimosti i bezopasnosti preparata Khondrogard u patsientov s osteoartrozom. RMZh. 2013;21(32):1624–1627. (In Russ).
  112. Torshin IYu, Lila AM, Naumov AV, et al. Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2020;13(4):388–399. (In Russ). doi: 10.17749/2070-4909/farmakoekonomika.2020.066
  113. Yang W, Sun C, He SQ, et al. The efficacy and safety of disease-modifying osteoarthritis drugs for knee and hip osteoarthritis– a systematic review and network meta-analysis. J Gen Intern Med. 2021;36(7):2085–2093. doi: 10.1007/s11606-021-06755-z
  114. Karateev AE, Nasonov EL, Ivashkin VT, et al. Ratsional’noe ispol’zovanie nesteroidnykh protivovospalitel’nykh preparatov. Klinicheskie rekomendatsii. Nauchno-prakticheskaya revmatologiya. 2018;56(S1):1–29. (In Russ). doi: 10.14412/rjtao20180
  115. Trijau S, Avouac J, Escalas C, et al. Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. 2010;18(8):1012–1018. doi: 10.1016/j.joca.2010.04.005
  116. The Royal Australian College of General Practitioners. Guideline for the management of knee and hip osteoarthritis. 2nd ed. East Melbourne, Vic: RACGP; 2018. 82 p.
  117. Cooper C, Chapurlat R, Al-Daghri N, et al. Safety of oral non-selective nonsteroidal anti-inflammatory drugs: what does the literature say? Drugs Aging. 2019;36(Suppl. 1):15–24. doi: 10.1007/s40266-019-00660-1
  118. Curtis E, Fuggle N, Shaw S, et al. Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging. 2019;36(Suppl. 1):25–44. doi: 10.1136/bmj.325.7365.619
  119. Builova TV. Otsenka kliniko-funktsional’nogo sostoyaniya bol’nykh s degenerativno-distroficheskimi zabolevaniyami tazobedrennykh sustavov v protsesse reabilitatsii [dissertation abstract]. Nizhny Novgorod; 2004. 46 p. (In Russ).
  120. Kurbanov SKh. Individual’naya reabilitatsiya posle endoprotezirovaniya tazobedrennogo sustava [dissertation abstract]. St. Petersburg; 2009. 38 p. (In Russ).
  121. Maksimov AV, Kir’yanova VV, Maksimova MA. The therapeutic application of magnetic fields. Fizioterapiya, bal’neologiya i reabilitatsiya. 2013;(3):34–39. (In Russ).
  122. Ponomarenko GN. Osnovy dokazatel’noi fizioterapii. St. Petersburg: VMedA; 2003. 224 p.
  123. Ponomarenko GN. Fizicheskaya i reabilitatsionnaya meditsina. Moscow: GEOTAR-Media; 2016. 688 p. (In Russ).
  124. Ponomarenko GN. Osnovy fizioterapii. Moscow: Meditsina; 2009. P. 171–172. (In Russ).
  125. Ushakov AA. Prakticheskaya fizioterapiya. Moscow: MIA; 2009. 364 p. (In Russ).
  126. Gafiyatullina GSh, Omel’chenko VP, Evtushenko BE, Chernikova IV. Fizioterapiya. Moscow: GEOTAR-Media; 2010. 272 p. (In Russ).
  127. Builova TV, Molochnyi VS, Dorofeeva GI, Kochetova NV. Reabilitatsiya bol’nykh posle endoprotezirovaniya tazobedrennogo sustava. Nizhny Novgorod: Nizhegorodskii NIITO; 2000. 28 p. (In Russ).
  128. Wuschech H, von Hehn U, Mikus E, Funk RH. Effects of PEMF on patients with osteoarthritis: Results of a prospective, placebo-controlled, double-blind study. Bioelectromagnetics. 2015;36(8):576–585. doi: 10.1002/bem.21942
  129. Iammarrone CS, Cadossi M, Sambri A, et al. Is there a role of pulsed electromagnetic fields in management of patellofemoral pain syndrome? Randomized controlled study at one year follow-up. Bioelectromagnetics. 2016;37(2):81–88. doi: 10.1002/bem.21953
  130. Trock DH, Bollet AJ, Dyer RH Jr, et al. A double-blind trial of the clinical effects of pulsed electromagnetic fields in osteoarthritis. J Rheumatol. 1993;20(3):456–460.
  131. Thamsborg G, Florescu A, Oturai P, et al. Treatment of knee osteoarthritis with pulsed electromagnetic fields: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage. 2005;13(7):575–581. doi: 10.1016/j.joca.2005.02.012
  132. Pipitone N, Scott DL. Magnetic pulse treatment for knee osteoarthritis: a randomised, double-blind, placebo-controlled study. Curr Med Res Opin. 2001;17(3):190–196. doi: 10.1185/0300799039117061
  133. Kennedy WF, Roberts CG, Zuege RC, Dicus WT. Use of pulsed electromagnetic fields in treatment of loosened cemented hip prostheses. A double-blind trial. Clin Orthop Relat Res. 1993;(286):198–205.
  134. Ay S, Evcik D. The effects of pulsed electromagnetic fields in the treatment of knee osteoarthritis: a randomized, placebo-controlled trial. Rheumatol Int. 2009;29(6):663–666. doi: 10.1007/s00296-008-0754-x
  135. Mohamed AE. Effect of pulsed magnetic field on lean muscle mass and fat mass in juvenile rheumatoid arthritis. Life Sci J. 2012;9(2s):222–228.
  136. Abdel-Aziem AA, Soliman ES, Mosaad DM, Draz AH. Effect of a physiotherapy rehabilitation program on knee osteoarthritis in patients with different pain intensities. J Phys Ther Sci. 2018;30(2):307–312. doi: 10.1589/jpts.30.307
  137. Adravanti P, Nicoletti S, Setti S, et al. Effect of pulsed electromagnetic field therapy in patients undergoing total knee arthroplasty: a randomized controlled trial. Int Orthop. 2014;38(2):397–403. doi: 10.1007/s00264-013-2216-7
  138. Iannitti T, Fistetto G, Esposito A, et al. Pulsed electromagnetic field therapy for management of osteoarthritis-related pain, stiffness and physical function: clinical experience in the elderly. Clin Interv Aging. 2013;8:1289–1293. doi: 10.2147/CIA.S35926
  139. Marcheggiani Muccioli GM, Grassi A, Setti S, et al. Conservative treatment of spontaneous osteonecrosis of the knee in the early stage: pulsed electromagnetic fields therapy. Eur J Radiol. 2013;82(3):530–537. doi: 10.1016/j.ejrad.2012.11.011
  140. Kulcu DG, Gulsen G, Altunok EC. Short-term efficacy of pulsed electromagnetic field therapy on pain and functional level in knee osteoarthritis: a randomized controlled study. Turk J Rheumatol. 2009;24(3):144–148.
  141. Minns Lowe CJ, Barker KL, Dewey M, Sackley CM. Effectiveness of physiotherapy exercise after knee arthroplasty for osteoarthritis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2007;335(7624):812. doi: 10.1136/bmj.39311.460093.BE
  142. Kramer JF, Speechley M, Bourne R, et al. Comparison of clinic- and home-based rehabilitation programs after total knee arthroplasty. Clin Orthop Relat Res. 2003;(410):225–234. doi: 10.1097/01.blo.0000063600.67412.11
  143. Fizicheskaya terapiya bol’nykh osteoartrozom: klinicheskie rekomendatsii. Moscow; 2015. 44 p. (In Russ).
  144. Piccirilli E, Oliva F, Murè MA, et al. Viscosupplementation with intra-articular hyaluronic acid for hip disorders. A systematic review and meta-analysis. Muscles Ligaments Tendons J. 2016;6(3):293–299. doi: 10.11138/mltj/2016.6.3.293
  145. Zhao Z, Ma JX, Ma XL. Different intra-articular injections as therapy for hip osteoarthritis: a systematic review and network meta-analysis. Arthroscopy. 2020;36(5):1452–1464.e2. doi: 10.1016/j.arthro.2019.09.043
  146. Wu B, Li YM, Liu YC. Efficacy of intra-articular hyaluronic acid injections in hip osteoarthritis: a meta-analysis of randomized controlled trials. Oncotarget. 2017;8(49):86865–86876. doi: 10.18632/oncotarget.20995
  147. van Middelkoop M, Arden NK, Atchia I, et al. The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids. Osteoarthritis Cartilage. 2016;24(7):1143–1152. doi: 10.1016/j.joca.2016.01.983
  148. Lieberman JR, Berry DJ, Mont MA, et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003;52:337–355.
  149. Solomon L, Warwick DJ, Nayagam S. Apley’s System of Orthopaedics and Fractures. Transl. from English. Ed by Tikhilov RM. Vol. 1. Moscow: Izdatel’stvo Panfilova; 2015. 392 p. (In Russ).
  150. Tikhilov RM, Shubnyakov II, Myasoedov AA, Irzhansky AA. Comparison of different core decompression techniques for treatment of early stages of osteonecrosis of the femoral head. Traumatology and Orthopedics of Russia. 2016;22(3):7–21. (In Russ). doi: 10.21823/2311-2905-2016-22-3-7-21
  151. Bennell KL, Hunter DJ, Paterson KL. Platelet-rich plasma for the management of hip and knee osteoarthritis. Curr Rheumatol Rep. 2017;19(5):24. doi: 10.1007/s11926-017-0652-x
  152. Medina-Porqueres I, Ortega-Castillo M, Muriel-Garcia A. Effectiveness of platelet-rich plasma in the management of hip osteoarthritis: a systematic review and meta-analysis. Clin Rheumatol. 2021;40(1):53–64. doi: 10.1007/s10067-020-05241-x
  153. Pak J, Lee JH, Kartolo WA, Lee SH. Cartilage regeneration in human with adipose tissue-derived stem cells: current status in clinical implications. Biomed Res Int. 2016;2016:4702674. doi: 10.1155/2016/4702674
  154. Gafarov KhZ. Lechenie detei i podrostkov s ortopedicheskimi zabolevaniyami nizhnikh konechnostei. Kazan’: Tatarskoe knizhnoe izdatel’stvo; 1995. 184 p. (In Russ).
  155. Hersche O, Casillas M, Ganz R. Indications for intertrochanteric osteotomy after periacetabular osteotomy for adult hip dysplasia. Clin Orthop Relat Res. 1998;(347):19–26.
  156. Petrosyan RKh. Differentsial’naya taktika vybora metoda operativnogo lecheniya displasticheskogo koksartroza (obzor literatury). Meditsinskii Vestnik Erebuni. 2012;(2):6–11. (In Russ).
  157. Paavilainen T, Hoikka V, Paavilainen P. Cementless total hip arthroplasty for congenitally dislocated or dysplastic hips: technique for replacement with a straight femoral component. Clin Orthop Relat Res. 1993;(297):71–81.
  158. Profilaktika infektsii oblasti khirurgicheskogo vmeshatel’stva. Klinicheskie rekomendatsii. Nizhny Novgorod: Remedium Privolzh’e; 2018. 72 p. (In Russ).
  159. European Physical and Rehabilitation Medicine Bodies Alliance. White Book on Physical and Rehabilitation Medicine in Europe. Introduction, Executive Summary and Methodology. Eur J Rehabil Med. 2018;54(2):125–155. doi: 10.23736/S1973-9087.18.05143-2
  160. Ivanova GE, Mel’nikova EV, Belkin AA, et al. How to organize medical rehabilitation? Vestnik vosstanovitel’noi meditsiny. 2018;(2):2–12. (In Russ).
  161. Federal’nye klinicheskie rekomendatsii. Reabilitatsiya pri endoprotezirovanii tazobedrennogo sustava v spetsializirovannom otdelenii statsionara. Vestnik vosstanovitel’noi meditsiny. 2016;(5):94–102. (In Russ).
  162. Ross CL. Optimal time of efficacy for using bone tissue engineered cell therapies and pulsed electromagnetic field. Cell Stem Cells Regen Med. 2017;3(1):6. doi: 10.16966/2472-6990.116
  163. Tabeeva D. Prakticheskoe rukovodstvo po iglorefleksoterapii. 4th ed. Moscow: MEDpress-inform; 2016. 440 p. (In Russ).
  164. Patel PD, Potts A, Froimson MI. The dislocating hip arthroplasty: prevention and treatment. J Arthroplasty. 2007;22(4 Suppl. 1):86–90. doi: 10.1016/j.arth.2006.12.111
  165. Irie S, Iida H, Nishimatsu H, et al. A test model of hip brace for prevention of dislocation after total hip arthroplasty (Zetton Band). Prosthet Orthot Int. 2002;26(3):253–256. doi: 10.1080/03093640208726656
  166. Baldwin KF, Dorr LD. The unstable total hip arthroplasty: the role of postoperative bracing. Instr Course Lect. 2001;50:289–293.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. Therapeutic and diagnostic algorithm for coxarthrosis.

Download (310KB)
Indexing metadata

Copyright (c) 2022 Tikhilov R.M., Lila A.M., Kochish A.Y., Alekseeva L.I., Shubnyakov I.I., Denisov A.O., Bozhkova S.A., Stafeev D.V., Builova T.V., Bodrova R.A., Tsykunov M.B., Israelyan Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies